Status:
COMPLETED
A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease
Lead Sponsor:
UCB Pharma
Conditions:
Parkinson's Disease
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
To test whether Parcopa, a new Orally Disintegrating Tablet of Carbidopa-Levodopa, has a faster onset of action, changes in the UPDRS Motor Exam score at intervals after a single dose of Parcopa or Si...
Detailed Description
See approved Package Insert for Adverse Event information.
Eligibility Criteria
Inclusion
- Stable Parkinson's disease
Exclusion
- idiopathic PD with Hoehn and Yahr state II or III
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00139880
Start Date
June 1 2005
End Date
August 1 2005
Last Update
September 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schwarz
Milwaukee, Wisconsin, United States